Perioperative treatment strategy for colorectal liver metastases

Liver metastasis is the leading cause of death from colorectal cancer.
Surgical treatment is so far the best choice for the treatment of colorectal liver metastases (CRLM). However, how to suitably select an individualized chemotherapy in perioperative period and surgical time and tool is still under controversy. Therefore, the key factors of improving the prognosis of patients with CRLM include overall evaluation of the patients and their preoperative examination outcomes, dividing patients into different groups based on different therapeutic goals, understanding different therapeutic goals of each group, selecting suitable chemotherapy and targeted therapy, ensuring surgical time (synchronous or stepwise resection) and tools (minimally invasive or open surgery) through multidisciplinary team model.